LGR4 and neoplasm: To quantify immunoreactivity of GPR48/LGR4 and BRAFV600E in PTC, we adopted a scoring system that combined the intensity and the distribution of positive staining: 0, no staining; +1, weak staining in focal tumor areas; +2, moderate staining in most tumors; and +3, strong staining in most tumors.